20.23
-0.56 (-2.69%)
| Penutupan Terdahulu | 20.79 |
| Buka | 20.93 |
| Jumlah Dagangan | 274,642 |
| Purata Dagangan (3B) | 383,680 |
| Modal Pasaran | 957,769,088 |
| Harga / Pendapatan (P/E Ke hadapan) | 250.00 |
| Harga / Jualan (P/S) | 10.55 |
| Harga / Buku (P/B) | 3.89 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Aug 2024 - 12 Aug 2024 |
| Margin Keuntungan | -31.32% |
| Margin Operasi (TTM) | -5.10% |
| EPS Cair (TTM) | -1.11 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 29.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 12.06% |
| Nisbah Semasa (MRQ) | 2.78 |
| Aliran Tunai Operasi (OCF TTM) | 9.10 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 10.14 M |
| Pulangan Atas Aset (ROA TTM) | -5.97% |
| Pulangan Atas Ekuiti (ROE TTM) | -15.04% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Bercampur | |
| Stok | BioLife Solutions, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | 2.63 |
|
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 1.94% |
| % Dimiliki oleh Institusi | 99.74% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 33.00 (Keybanc, 63.12%) | Beli |
| Median | 31.00 (53.24%) | |
| Rendah | 27.00 (HC Wainwright & Co., 33.47%) | Beli |
| Purata | 30.60 (51.26%) | |
| Jumlah | 5 Beli | |
| Harga Purata @ Panggilan | 24.30 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Benchmark | 19 Dec 2024 | 30.00 (48.29%) | Beli | 26.11 |
| Keybanc | 13 Dec 2024 | 33.00 (63.12%) | Beli | 26.70 |
| HC Wainwright & Co. | 18 Nov 2024 | 27.00 (33.47%) | Beli | 20.47 |
| 30 Sep 2024 | 29.00 (43.35%) | Beli | 25.04 | |
| Craig-Hallum | 13 Nov 2024 | 32.00 (58.18%) | Beli | 24.11 |
| TD Cowen | 13 Nov 2024 | 31.00 (53.24%) | Beli | 24.11 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 16 Dec 2024 | Pengumuman | BioLife Solutions Appoints Tony J. Hunt to its Board of Directors |
| 14 Nov 2024 | Pengumuman | BioLife Solutions Announces $6.1 million Sale of its Custom Biogenic Systems Freezer Subsidiary |
| 12 Nov 2024 | Pengumuman | BioLife Solutions Announces $73 Million Sale of its SciSafe Biostorage Subsidiary |
| 12 Nov 2024 | Pengumuman | BioLife Solutions Reports Third Quarter 2024 Financial Results |
| 31 Oct 2024 | Pengumuman | BioLife Solutions to Report Third Quarter 2024 Financial Results and Business Update on November 12, 2024 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |